Medical treatment of moderate to severe Crohn's disease (original) (raw)

Oral budesonide as maintenance treatment for Crohn's disease: A placebo- controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

Frances Martin

Gastroenterology, 1996

View PDFchevron_right

Budesonide in the treatment of Crohn's disease: a meta-analysis

Maurizio Koch, Roberto Luchetti

Alimentary Pharmacology and Therapeutics, 2000

View PDFchevron_right

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial

Limas Kupcinskas, Ivan Bunganič, Daniel Tuculanu, Roland Greinwald

Journal of Crohn's and Colitis, 2014

View PDFchevron_right

Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: A multicentre, double-blind, randomized, parallel-group Phase II study

Satoshi Motoya

Journal of Crohn's and Colitis, 2013

View PDFchevron_right

Budesonide for maintenance of remission in Crohnʼs disease: A systematic review and meta-analysis for the Cochrane Collaboration

Eric I Benchimol

Inflammatory Bowel Diseases, 2008

View PDFchevron_right

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease

Cosimo Prantera

Gastroenterology, 1999

View PDFchevron_right

Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules

Alan Lobo

Alimentary Pharmacology and Therapeutics, 2001

View PDFchevron_right

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohnʼs disease: A randomized placebo-controlled trial

Roland Greinwald

Inflammatory Bowel Diseases, 2009

View PDFchevron_right

Safety and effectiveness of long-term budesonide treatment in maintaining remission in patients with mild-to-moderate Crohnʼs disease

Antonio Tursi

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial

Eric Drouin

Gastroenterology, 2001

View PDFchevron_right

Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease

Martin Bergstrand

Alimentary Pharmacology and Therapeutics, 2003

View PDFchevron_right

Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease

Mathias Plauth

Gut, 1998

View PDFchevron_right

Oral budesonide for maintenance of remission of Crohn’s disease: a pooled safety analysis

Bengt-ake Bengtsson

Alimentary Pharmacology & Therapeutics, 2009

View PDFchevron_right

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

Ivan Bunganič, Davor Štimac

Gastroenterology, 2011

View PDFchevron_right

Advances in medical therapy for Crohn’s disease

Marco Daperno

Current Gastroenterology Reports, 2004

View PDFchevron_right

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life

Derek Jewell

The American journal of gastroenterology, 2002

View PDFchevron_right

Evidence-based treatment algorithm for mild to moderate Crohn's disease

William Sandborn

The American journal of gastroenterology, 2003

View PDFchevron_right

Budesonide Use and Hospitalization Rate in Crohn's Disease: Results From a Cohort at a Tertiary Care IBD Referral Center

Fenglong Xie

Journal of clinical medicine research, 2016

View PDFchevron_right

Pharmacological Management of Crohn's Disease: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 131

Lisa Wilson

2014

View PDFchevron_right

Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-Dependent Crohnʼs Disease

Michael Sfakianakis

Inflammatory Bowel Diseases, 2009

View PDFchevron_right

Budesonide for ulcerative colitis

Amado Salvador Peña

Falk Symposium

View PDFchevron_right

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Kaija-leena Kolho

Journal of Crohn's and Colitis, 2010

View PDFchevron_right

Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis

Pilar Nos

Clinical and Experimental Gastroenterology, 2014

View PDFchevron_right

Crohn’s disease - treatment with biological medication

Cyrla Zaltman

Revista da Associação Médica Brasileira

View PDFchevron_right

Conventional and Future Therapies for Crohn's Disease

Simon Campbell

OBM Hepatology and Gastroenterology, 2019

View PDFchevron_right

Advances in the treatment of Crohn’s disease

William Sandborn

View PDFchevron_right

Crohn’s disease: Current approaches in the management and remission

sailaja rao

The Pharma Innovation Journal, 2019

View PDFchevron_right

Medical treatment of moderate to severe Crohn's disease (original) (raw)

Related papers